MedTrace Logo

Cancer of Esophagogastric Junction: Optimized Sweet Versus Ivor-Lewis

NCT06162767 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 240

Last updated 2024-03-21

No results posted yet for this study

Summary

This study is being done to see whether Optimized Sweet Procedure is superior than the Ivor-Lewis Procedure Esophagectomy with better long-term outcome and acceptable postoperative short-term outcome or not.

Conditions

  • Esophagogastric Junction Carcinoma

Interventions

PROCEDURE

Esophagectomy by Ivor-Lewis Procedure

Esophagectomy was conducted by Ivor-Lewis Procedure.

PROCEDURE

Esophagectomy by Optimized Sweet Procedure

Esophagectomy was conducted by Optimized Sweet Procedure.

Sponsors & Collaborators

  • The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

    lead OTHER

Principal Investigators

  • Louqian Zhang, MD · The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-12-01
Primary Completion
2026-06-30
Completion
2028-06-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06162767 on ClinicalTrials.gov